Internal Medicine, Pulmonary Disease · Columbia, SC
NPI
1346258746
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3016 Longtown Commons Dr
Columbia, SC, 29229
Phone (803) 936-8900
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
3,495 services
Medicare patients, 2024
952
Average age 74
Drug cost, 2024
$11.1M
5,030 prescriptions
Company payments, 2025
$621
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlton G Cauthen was code 99214 (office e&m - established), 814 times for 522 patients. In total Carlton G Cauthen billed 3,495 services in 28 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 814 | 522 | $85.70 | $70K |
| 94375 Pulmonary Function Testing | Office | 782 | 500 | $26.74 | $21K |
| 94618 Pulmonary Function Testing | Office | 283 | 241 | $24.32 | $6,883 |
| 94729 Pulmonary Function Testing | Office | 255 | 235 | $38.37 | $9,785 |
| 99204 Office E&M - New | Office | 240 | 240 | $109.48 | $26K |
| 99213 Office E&M - Established | Office | 235 | 219 | $64.02 | $15K |
| 94726 Pulmonary Function Testing | Office | 214 | 214 | $39.33 | $8,417 |
| 95800 Sleep Study | Facility | 126 | 126 | $28.82 | $3,631 |
| 99203 Office E&M - New | Office | 83 | 83 | $76.26 | $6,330 |
| 95811 Sleep Study | Facility | 73 | 73 | $90.32 | $6,594 |
| 71046 X-ray - Chest | Office | 58 | 58 | $16.61 | $964 |
| 95810 Sleep Study | Facility | 58 | 58 | $84.88 | $4,923 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 49 | $12.45 | $660 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 34 | 32 | $26.19 | $890 |
| 99222 Hospital E&M - Initial | Facility | 34 | 34 | $96.28 | $3,274 |
By year: 2022 $264K for 5,264 services; 2023 $221K for 4,249 services; 2024 $196K for 3,495 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 15 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Carlton G Cauthen prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 834 prescriptions and refills. In total Carlton G Cauthen wrote 5,030 Medicare prescriptions that cost $11.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 834 | 989 | 330 | $27K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 517 | 757 | 139 | $475K |
| Tadalafil Generic | 248 | 268 | 40 | $257K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 217 | 278 | 63 | $169K |
| Prednisone Generic | 197 | 406 | 78 | $1,166 |
| Breo Ellipta Fluticasone/Vilanterol | 171 | 245 | 50 | $95K |
| Opsumit Macitentan | 158 | 160 | 15 | $2.0M |
| Montelukast Sodium Generic | 156 | 412 | 67 | $2,612 |
| Fluticasone Propionate Generic | 145 | 287 | 75 | $2,586 |
| Symbicort Budesonide/Formoterol Fumarate | 129 | 170 | 40 | $40K |
| Spiriva Respimat Tiotropium Bromide | 127 | 181 | 41 | $91K |
| Famotidine Generic | 118 | 286 | 47 | $2,322 |
| Methylprednisolone Generic | 102 | 108 | 81 | $712 |
| Uptravi Selexipag | 100 | 100 | Under 11 | $2.2M |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 94 | 149 | 32 | $68K |
Brand drugs: 2,794 claims; generic drugs: 2,222 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlton G Cauthen $621 ($621 in general payments such as food, travel and fees) from 11 companies. The largest payer was Verona Pharma, Inc. with $240.
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. VRNA | 16 | $240 |
| Merck Sharp & Dohme LLC MRK | 4 | $87.69 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $71.21 |
| United Therapeutics Corporation UTHR | 2 | $40.97 |
| GlaxoSmithKline, LLC. GSK | 2 | $38.99 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $30.95 |
| Axsome Therapeutics, Inc. AXSM | 1 | $26.3 |
| Grifols USA, LLC | 1 | $24.58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.01 |
| Harmony Biosciences LLC HRMY | 1 | $19.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.